The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 Diabetes
Phase of Trial: Phase II
Latest Information Update: 16 Jun 2017
At a glance
- Drugs Glucagon (Primary) ; Glucose
- Indications Hypoglycaemia; Type 1 diabetes mellitus
- Focus Therapeutic Use
- 16 Jun 2017 According to a Xeris Pharmaceuticals media release, results were presented at the 77th Scientific Session of the American Diabetes Association (ADA).
- 16 Jun 2017 Results published in a Xeris Pharmaceuticals media release.
- 10 Mar 2017 Status changed from active, no longer recruiting to completed.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History